[HTML][HTML] Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatment
Y Huang, X Guo, Y Wu, X Chen, L Feng, N Xie… - … and Targeted Therapy, 2024 - nature.com
Inflammation-associated diseases encompass a range of infectious diseases and non-
infectious inflammatory diseases, which continuously pose one of the most serious threats to …
infectious inflammatory diseases, which continuously pose one of the most serious threats to …
[HTML][HTML] Translational medicine for acute lung injury
J Zhang, Y Guo, M Mak, Z Tao - Journal of Translational Medicine, 2024 - Springer
Acute lung injury (ALI) is a complex disease with numerous causes. This review begins with
a discussion of disease development from direct or indirect pulmonary insults, as well as …
a discussion of disease development from direct or indirect pulmonary insults, as well as …
An inhalable hybrid biomimetic nanoplatform for sequential drug release and remodeling lung immune homeostasis in acute lung injury treatment
Interactions of lung macrophages and recruited neutrophils with the lung microenvironment
continuously aggravate the dysregulation of lung inflammation in the pathogenesis of acute …
continuously aggravate the dysregulation of lung inflammation in the pathogenesis of acute …
Protein Coronas Derived from Mucus Act as Both Spear and Shield to Regulate Transferrin Functionalized Nanoparticle Transcellular Transport in Enterocytes
D Yang, Y Feng, Y Yuan, L Zhang, Y Zhou… - ACS …, 2024 - ACS Publications
The epithelial mucosa is a key biological barrier faced by gastrointestinal, intraoral,
intranasal, ocular, and vaginal drug delivery. Ligand-modified nanoparticles demonstrate …
intranasal, ocular, and vaginal drug delivery. Ligand-modified nanoparticles demonstrate …
Emerging application of nanomedicine-based therapy in acute respiratory distress syndrome
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are serious lung
injuries caused by various factors, leading to increased permeability of the alveolar-capillary …
injuries caused by various factors, leading to increased permeability of the alveolar-capillary …
[HTML][HTML] New therapeutics for extracellular vesicles: delivering CRISPR for cancer treatment
B Yan, Y Liang - International Journal of Molecular Sciences, 2022 - mdpi.com
Cancers are defined by genetic defects, which underlines the prospect of using gene
therapy in patient care. During the past decade, CRISPR technology has rapidly evolved …
therapy in patient care. During the past decade, CRISPR technology has rapidly evolved …
Preparation of Budesonide-Loaded Liposomal Nanoparticles for Pulmonary Delivery and Their Therapeutic Effect in OVA-Induced Asthma in Mice
X Zuo, Y Gu, X Guo, W Zheng, H Zheng… - International journal …, 2024 - Taylor & Francis
Purpose Inhaled corticosteroids, including budesonide (BUD), are widely employed for the
treatment of asthma. However, the frequent use of corticosteroids is associated with …
treatment of asthma. However, the frequent use of corticosteroids is associated with …
[HTML][HTML] Discovery, validation, and prodrug design of an ACE2 activator for treating bacterial infection-induced lung inflammation
Exacerbated inflammatory responses can be detrimental and pose fatal threats to the host,
as exemplified by the global impact of the COVID-19 pandemic, resulting in millions of …
as exemplified by the global impact of the COVID-19 pandemic, resulting in millions of …
Therapeutic effects of tea polyphenol-loaded nanoparticles coated with platelet membranes on LPS-induced lung injury
H Jin, Y Zhao, Y Yao, J Zhao, R Luo, S Fan… - Biomaterials …, 2023 - pubs.rsc.org
Patients with ALI (acute lung injury)/ARDS (acute respiratory distress syndrome) are often
septic and with poor prognosis, which leads to a high mortality rate of 25–40%. Despite the …
septic and with poor prognosis, which leads to a high mortality rate of 25–40%. Despite the …
[HTML][HTML] Molecular mechanisms related to responses to oxidative stress and antioxidative therapies in COVID-19: a systematic review
The coronavirus disease (COVID-19) pandemic is a leading global health and economic
challenge. What defines the disease's progression is not entirely understood, but there are …
challenge. What defines the disease's progression is not entirely understood, but there are …